Isolated proximal anomalous connections of the coronary arteries (ANOCOR) are rare and sometimes raise diagnostic and therapeutic problems. The prognosis depends mainly on the initial course of the ectopic vessel. In the current guidelines, surgical repair is recommanded for high risk ANOCOR. The lack of controlled studies and scarcity of data concerning the long-term evaluation of ANOCOR corrected or not may explain the discordance noticed between recommandations and practices. Large-scale prospective multicenter registries dedicated to ANOCOR are needed to achieve a better understanding of the clinical profile and the impact of correction on the natural history of these congenital coronary abnormalities.
Isolated proximal anomalous connections of the coronary arteries (ANOCOR) are rare and sometimes raise diagnostic and therapeutic problems. The prognosis depends mainly on the initial course of the ectopic vessel. In the current guidelines, surgical repair is recommanded for high risk ANOCOR. The lack of controlled studies and scarcity of data concerning the long-term evaluation of ANOCOR corrected or not may explain the discordance noticed between recommandations and practices. Large-scale prospective multicenter registries dedicated to ANOCOR are needed to achieve a better understanding of the clinical profile and the impact of correction on the natural history of these congenital coronary abnormalities.
The ANOCOR study began 31st January, 2010 with an inclusion period of 3 years. More than 450 young people (≥15-year-old) and adults have been included by 71 interventional cardiologists from the Interventional Working Group (GACI) of the French Society of Cardiology. A 5-years follow-up was scheduled.
Clinical characteristics, angiographic patterns and computed tomography images, as well as the initial management of the ANOCOR cohort patients will be presented.
Stents in pediatric and adult congenital cardiac catheterization in France in 2013
Sébastien Hascoët (1), Zakaria Jalal (2), Alban Baruteau (3), Lucia Mauri (4), Hélène Bouvaist (5), Ali Houeijeh (6), Aurelie Chalard (7), Ivan Bouzguenda (8), Jean René Lusson (7), Philippe Acar (9), Jean Francois Piéchaud (8), Jean Benoit Thambo (2), Jean Francois Godart (6), Alain Fraisse (4) (1) CHU Toulouse, Hôpital des enfants, Pediatric cardiac surgery, Toulouse, Pediatric and congenital cardiology, Bordeaux, Pediatric cardiology, Clermont Ferrand, Pediatric cardiology, Massy, CHU Toulouse, Hôpital des enfants, Pediatric cardiology, Toulouse, France Stents have contributed to the development of the interventional catheterization of congenital heart diseases (CHD). The aim of this study was to describe current indications and results.
Methods: Participation to this study was proposed to all catheterization laboratories specialized in CHD in France (M3C network). All cases with stents implantation in 2013 in pediatric and adult CHD were retrospectively included. Adverse events were assessed using the Bergersen classification. Risk markers were searched using univariate and multivariate analysis.
Results: 174 stents were implanted in 127 patients. Patients were aged 15.7±15.1 year old (min 5 day-old -max 70 year-old). Main indications were transcatheter pulmonary valve replacement (prestenting and revalvulation; n=29 patients, 23.0%), pulmonary artery branches angioplasty (n=34, 27.0%), aortic coarctation or recoarctation stenting (n=37, 29.4%) and ductus arteriosus stenting (n=11, 8.7%). 18 Patients (14.3%) were under one-year old and 35 (27.8%) were over 18 year-old. Main pathologies were tetralogy of Fallot and variants n=45, 35.7%) , and aortic coarctation (ACC-CHD 9.2, n=36, 28.6%). More than one stent was implanted in 32 procedures (24.4%, max. 5 stents). Main stents implanted were the CP stent (33.0%), EV3 LD max (22.0%), Valeo (16.2%) and valved stents (15.0%). 98.5% Procedures were considered as successful. Adverse events were observed in 16.7% procedures (stent related in 12.1% procedures). Serious adverse events were observed in 12.9%. After uni-and multivariate adjustment, only procedure type was related to the risk of total adverse events but not to stent related adverse events. Age, weight, center, type of stents, genetic disorder and type of CHD were not significantly related to the risk of adverse events.
Conclusion:
Stents are used in various CHD catheterization procedures, from infancy to adult age. Adverse events rate is significant and seems related to the type of procedure.
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Incidence and outcomes of right sided endocarditis in patients with congenital heart diseases with surgical or transcatheter pulmonary valve implantation Sophie Malekzadeh-Milani (1), Magalie Ladouceur (1), Laurence Iserin (2), Damien Bonnet (1), Younes Boudjemline (1) (
1) CHU Hôpital Necker Enfants Malades-APHP, Cardiologie pédia-trique, Paris, France -(2) CHU Hôpital Européen Georges Pompidou (HEGP) -APHP, Cardiologie, Paris, France
Objectives: To evaluate and compare the incidence, clinical presentations and outcomes of right-sided infective endocarditis in patients with surgical pulmonary conduit versus those with percutaneous pulmonary valve implantation.
Methods: All consecutive patients who received a pulmonary valve surgically or percutaneously between January 2009 and June 2013 were included and evaluated for endocarditis.
Results: Of the 195 conduits surgically implanted (surgical group) and 93 Melody valves percutaneously implanted (PPVI group), the person-time incidence rates of endocarditis were 1.2 and 3.9 cases per 100 person-years in the surgical and PPVI groups respectively (p=0.03). Clinical presentations, microbiology and outcomes were comparable in both groups. The implantationendocarditis time interval was much shorter in the Melody valve patients (p=0.0065). On multivariate analysis, only a past history of endocarditis was found to significantly correlate with endocarditis (p=0.004). Probability of survival at 12, 24 and 36 months was 99.5%, 93.8%, 93.8% in the surgical-group and 98.9%, 96.8%, 92.3% in the Melody-group respectively (p=0.6). Event free probability including endocarditis was comparable (p=0.1).
Conclusion:
There is a high person-time incidence of endocarditis in patients with Melody valve when compared to surgically implanted pulmonary valves. Clinical features and microbiology were comparable in both groups.
Abstract 0418 -Figure: RV Transverse strain predicts event-free survival
The possible role of the bovine jugular vein in the development of endocarditis is concerning. However, despite a higher incidence of Melody valve endocarditis, probabilities of survival and event free survival were similar to the surgical group. Aims: Our objective was to evaluate the mid-term safety and efficacy of cardiac resynchronization (CRT) in this population.
Methods:
We collected retrospectively every adverse events due to biventricular pacing of patients with corrected tetralogy of Fallot implanted with CRT system in our department. We also compared clinical datas (NYHA score), stress tests, ECG, echocardiographic results before implantation, at 6 months of follow-up and at the last evaluation.
Results:From August 2005 to Septembre 2009, 9 patients were implanted with CRT system, 6 (66,7%) with transvenous leads and 3 (33,4%) with epicardic leads, mostly composed of men (6, 66,7%) with a mean age of 34,2±14,5 years, 4 (44,5%) had an Implantable Cardioverter Defibrillator (ICD) function. During a median follow-up of 65 months , no main adverse event was reported, we had 1 atrial lead dislogement, 3 (33%) lead disfunctions causing only 1 (11%) resynchronisation failure and 1 (11%) intermittent phrenic nerve stimulation. CRT were associated with lower NHYA score (1,4±0,52 then 1,3±0,8 vs 2±0,4, p<0,05) and an improved exercise tolerance (100±21,6W then 112,9±12,9W, vs. 71,3±26,2W, p<0,05) at 6 months and at the end of follow-up. Mean RVEF was increased (54,3±8,2 vs. 38,5±7,5; p=0,035 and so was LVEF (53,8±8,3% vs. 48,8±8,8%, p=0,04).
Conclusion:
CRT in corrected tetralogy of Fallot anad right ventricule failure is safe and seems to be associated with an improvement of patient's functional status. This first study on CRT in this population should be confirmed by a large prospective randomised multicentric clinical trial.
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Fate and evolution of patients with congenital heart disease: Moroccan experience Laila Bouzouba, A.Drighil, R.Habbal CHU Ibn Rochd, Cardiologie, Casablanca, Maroc Congenital heart disease are frequent and often severe. Their surgical treatment restores the closest possible physiological function. In Under-developing countries, the therapeutic management of these heart disease is limited by the lack of resources and skills. The objective of this work was to study the fate of patients in whom the indication for surgery was raised A retrospective descriptive study conducted at the University Hospital of Casablanca over 5 years (décember 2008 to décember 2013). We have collected 1908 patients with congenital heart disease, 738 (38.7%) had a surgical indication. 50% of patients were operated, 22.6% non-operated. In patients operated, the median age of surgery: 3 years [6days-51years], the median time between diagnosis and surgery: 4months [9days-5yrs]. It was a IVC (30%) and a IAC (20.4%). Favorable evolution in82.9%. Death occurred in15, 2% which 62.5% immediatly in postoperative period. Mortality varied with the centre (18% for patients operated in UHC and 24% privately center and 3.4% in abroad). In non-operated patients, 50%were due to lack of funds, 34.3% awaiting a surgical date and15.7% refused surgery. 34.5% of non-operated patients died. The quality of life of survival patients is affected in 68% in terms of physical health, and 76%of patients had mental health degradation.
Although the indication for surgery of congenital heart disease is a medical necessity, the outcome of these patients in Moroccan context depends on several technical and affordability considerations. This results in a high mortality rate and also adult carriers of congenital heart disease with impaired quality of life.
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Follow-up of children or teenagers with paroxysmal supraventricular tachycardia but without preexcitation syndrome Béatrice Brembilla-Perrot (1), Anne Moulin-Zinsch (2), Jean Paul Lethor (2), Carole Nrecaj-Jager (2), Anne Tisserant (2) Paroxysmal supraventricular tachycardia's (SVT) are considered of benign if ECG in sinus rhythm (SR) is normal, but their occurrence in children/teenagers is always associated with an anxiousness of parents, child and doctors. The purpose of study was to report the clinical and electrophysiological data of children with SVT, their follow-up and management.
Methods: 147 children and teenagers aged from 5 to 19 years (mean 15±3) with a normal ECG in SR were studied for spontaneous SVT. Transesophageal electrophysiological study was systematic. Children were followed from 1 month to 13 years (mean 2±2 years).
Results: SVT was poorly-tolerated in 26 patients (18%). SVT was related to atrioventricular (AV nodal re-entrant tachycardia (RT) (AVNRT) in 107 children, either typical in 95 children or atypical AVNRT in 12 children, to an AVRT related to a concealed accessory pathway (AP) in 40 patients (27%). Radiofrequency (RF) of the slow pathway (n=50) or AP (n=32) was performed in absence of general anaesthesia in 82 patients (56%) from 1 month up to 13 years after initial evaluation (mean 2±2 years). Failure of ablation (frequently for refuse to continue) was frequent and occurred in 15 children (26%), 7 with AVNRT (14%), 9 with AP (28%) (0.08). Recurrence of SVT occurred in 4 patients (5%) and 14 (17.5%) have still sinus tachycardia-related symptoms. In 13 children treated by antiarrhythmic drug (AAD) or betablockers, SVT recurred in 4 children; 2 children presented AAD-related syncope. In 52 untreated patients one death was noted after AAD infusion used to stop SVT, but other patients remained asymptomatic or had short and well-tolerated SVT's.
Conclusions:
The management of SVT in children remains difficult despite the development of RF ablation of SVT. Failure of ablation remains higher than in adults for several reasons. Child remains symptomatic in 17.5% of cases after ablation. One third of them had a spontaneous favourable evolution. However in symptomatic children with frequent SVT's despite antiarrhythmic drugs or betablockers, ablation should be indicated to avoid drugsrelated adverse effects.
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Right ventricular systolic strain evolution during peri-operative management of congenital heart diseases Clement Karsenty (1), Sébastien Hascoët (2), Khaled Hadeed (1), Romain Amadieu (1), Xavier Alacoque (3), Rose Fesseau (3), Yves Dulac (1), Sophie Breinig (4), Bertrand Leobon (2), Philippe Acar (1 Background: RV systolic strain evolution during peri-operative management of congenital heart diseases (CHD) is unknown.
Methods:
In this prospective study, RV peak systolic strain (PSS) was measured using 2D speckle tracking echocardiography (Qlab10.0 software, Philips) in 39 children undergoing surgery of a CHD (Median age: 17 months, min 6 day-old, max 14.3 year-old). Three measures were performed the day before surgery, few hours after the surgery and before discharge and compared
